About Us:

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.


121 Seaport Blvd

Boston, MA 02210


Brief summary of the
materials and/or video content:

Understanding the Mechanism of Disease and Effect of LOW ALP in the human body


Have questions? Please contact:

Madoc Walmsley - 501-247-4961